Biocon

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE376G01013
  • NSEID: BIOCON
  • BSEID: 532523
INR
390.45
10.05 (2.64%)
BSENSE

May 11

BSE+NSE Vol: 1.35 cr

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
16,927.00
15,261.70
14,755.70
11,174.20
8,184.00
7,143.10
6,300.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
16,927.00
15,261.70
14,755.70
11,174.20
8,184.00
7,143.10
6,300.50
Raw Material Cost
5,277.60
4,276.70
5,071.90
3,191.10
2,813.90
2,430.20
2,104.90
Purchase of Finished goods
1,362.60
626.60
682.70
626.10
161.10
103.60
85.40
(Increase) / Decrease In Stocks
-949.50
294.20
-856.70
-154.10
-256.60
-290.10
-200.80
Employee Cost
3,508.00
3,144.40
2,664.10
2,181.00
1,880.10
1,741.00
1,458.80
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
4,273.00
3,753.50
3,895.00
2,818.40
1,615.30
1,505.60
1,249.10
Total Expenditure (Excl Depreciation)
13,471.70
12,095.40
11,457.00
8,662.50
6,213.80
5,490.30
4,697.40
Operating Profit (PBDIT) excl Other Income
3,455.30
3,166.30
3,298.70
2,511.70
1,970.20
1,652.80
1,603.10
Other Income
342.50
1,208.20
865.50
375.90
212.70
254.50
161.40
Operating Profit (PBDIT)
3,797.80
4,374.50
4,164.20
2,887.60
2,182.90
1,907.30
1,764.50
Interest
990.30
897.40
974.40
419.00
67.60
57.70
64.90
Exceptional Items
-402.90
96.50
-11.60
-291.40
-111.10
12.60
38.60
Gross Profit (PBDT)
2,404.60
3,573.60
3,178.20
2,177.20
2,004.20
1,862.20
1,767.10
Depreciation
1,956.70
1,687.00
1,568.80
1,113.10
814.20
715.10
552.20
Profit Before Tax
447.90
1,886.60
1,609.40
1,064.10
1,190.00
1,147.10
1,214.90
Tax
79.10
457.20
227.40
254.10
211.50
221.50
315.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
368.80
1,429.40
1,382.00
810.00
978.50
925.60
899.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
-28.90
Net Profit
368.80
1,429.40
1,382.00
810.00
978.50
925.60
870.90
Share in Profit of Associates
0.00
0.00
-84.20
-167.00
-206.90
-79.40
0.00
Minority Interest
16.80
-416.10
-275.30
-180.30
-123.20
-105.70
-122.70
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
385.60
1,013.30
1,022.50
462.70
648.40
740.50
748.20
Equity Capital
810.50
600.30
600.30
600.30
600.30
600.00
600.00
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
33,221.30
21,043.70
19,183.40
17,266.60
7,832.20
7,026.90
6,105.80
Earnings per share (EPS)
2.38
8.44
8.52
3.85
5.4
6.17
6.24
Diluted Earnings per share
2.82
8.46
8.54
3.87
5.42
6.19
6.3
Operating Profit Margin (Excl OI)
20.59%
21.04%
23.24%
22.48%
24.07%
23.14%
25.44%
Gross Profit Margin
14.33%
23.74%
22.39%
19.48%
24.49%
26.07%
28.05%
PAT Margin
2.2%
9.5%
9.14%
5.75%
9.43%
11.85%
14.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 10.91% vs 3.43% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -61.95% vs -0.90% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 9.13% vs -4.01% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 10.35% vs -7.90% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Biocon With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
16,927.00
6,812.90
10,114.10
148.46%
Other Operating Income
0.00
0.00
0.00
Total Operating income
16,927.00
6,812.90
10,114.10
148.46%
Raw Material Cost
5,277.60
2,794.34
2,483.26
88.87%
Purchase of Finished goods
1,362.60
172.56
1,190.04
689.64%
(Increase) / Decrease In Stocks
-949.50
-271.44
-678.06
-249.80%
Employee Cost
3,508.00
895.45
2,612.55
291.76%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
4,273.00
1,444.28
2,828.72
195.86%
Total Expenditure (Excl Depreciation)
13,471.70
5,035.19
8,436.51
167.55%
Operating Profit (PBDIT) excl Other Income
3,455.30
1,777.71
1,677.59
94.37%
Other Income
342.50
54.95
287.55
523.29%
Operating Profit (PBDIT)
3,797.80
1,832.66
1,965.14
107.23%
Interest
990.30
170.73
819.57
480.04%
Exceptional Items
-402.90
0.00
-402.90
Gross Profit (PBDT)
2,404.60
1,661.93
742.67
44.69%
Depreciation
1,956.70
480.05
1,476.65
307.60%
Profit Before Tax
447.90
1,181.88
-733.98
-62.10%
Tax
79.10
292.03
-212.93
-72.91%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
368.80
889.85
-521.05
-58.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
368.80
889.85
-521.05
-58.55%
Share in Profit of Associates
0.00
0.29
-0.29
-100.00%
Minority Interest
16.80
-1.35
18.15
1,344.44%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
385.60
888.79
-503.19
-56.62%
Equity Capital
810.50
107.97
702.53
650.67%
Face Value
5.00
2.00
0.00
Reserves
33,221.30
5,192.09
28,029.21
539.84%
Earnings per share (EPS)
2.38
16.46
-14.08
-85.54%
Diluted Earnings per share
2.82
16.45
-13.63
-82.86%
Operating Profit Margin (Excl OI)
20.59%
26.09%
0.00
-5.50%
Gross Profit Margin
14.33%
24.39%
0.00
-10.06%
PAT Margin
2.20%
13.06%
0.00
-10.86%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 16,927.00 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 10.91% vs 3.43% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 385.60 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -61.95% vs -0.90% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,455.30 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 9.13% vs -4.01% in Mar 2025

Annual - Interest
Interest 990.30 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 10.35% vs -7.90% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.59%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025